Healthcare and Biotech Are Driving 2018's IPO Surge

The first half of 2018 brought a rebound in the IPO market not seen for the past 20 years, driven to large extent by an appetite for healthcare and technology stocks.

So far this year, 120 companies have issued IPOs on U.S. exchanges raising a total of $35.2 billion, according to the Wall Street Journal citing Dealogic, which keeps data since 1995. In the past 12 months, more than 60% of the IPOs have been focused in healthcare and tech stocks, according to data from Renaissance Capital.

Click here to read the full article.

Fund holdings and sector allocations are subject to change at any time and are not recommendations to buy or sell any security. For PRCGX holdings click here. For PREOX holdings click here. For PLOWX holdings click here.

Opinions expressed are those of the author and are subject to change, are not guaranteed and are not intended to be a forecast or as a recommendation to buy or sell any security.  References to other mutual funds should not be interpreted as an offer of these securities.


Invest With Us